TrialAmerican journal of hematology2018

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.

James Bussel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.